Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission

Department of Anesthesiology, University of Rochester, New York.

The transmission of echocardiographic contrast medium and the cyclic changes in left ventricular videodensity during transpulmonary contrast echocardiography were investigated in nine adult volunteers with the use of intravenous injections of sonicated albumin (microbubble size 5.2 +/- 2.6 microns). Right and left ventricular and myocardial contrast were quantitated by videodensitometric analysis. The injections caused no symptoms, and no hemodynamic or electrocardiographic changes were observed. All injections resulted in right ventricular contrast. Mean peak right ventricular videodensity was 75 +/- 48 at end-diastole and 61 +/- 36 gray scale U/pixel at end-systole (p less than 0.05). Seventy-eight percent of injections resulted in left ventricular contrast with a mean peak videodensity of 21 +/- 33 gray scale U/pixel. Early systole was associated with a rapid decrease in left ventricular contrast intensity with near total disappearance of contrast by end-systole (from 23 +/- 33 and 17 +/- 23 U/pixel at end-diastole to 6 +/- 10 and 3 +/- 2 at end-systole at the left ventricular base and apex, respectively; p less than 0.05). None of the injections resulted in myocardial contrast enhancement by visual or quantitative analysis. Thus, left ventricular contrast echocardiography can be achieved after intravenous injections of sonicated albumin. Transpulmonary left ventricular contrast echocardiography is associated with near total disappearance of contrast during systole. This may be secondary to the destruction of microbubbles by the high left ventricular systolic pressure. These findings may help explain the limited success of this technique thus far for myocardial perfusion imaging.

This article has been cited by other articles:

				M.- X. Tang, H. Mulvana, T. Gauthier, A. K. P. Lim, D. O. Cosgrove, R. J. Eckersley, and E. Stride Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability Interface Focus, August 6, 2011; 1(4): 520 - 539. [Abstract] [Full Text] [PDF]

				G. Mychaskiw II, A. E. Badr, R. Tibbs, B. R. Clower, and J. H. Zhang Optison (FS069) Disrupts the Blood-Brain Barrier in Rats Anesth. Analg., October 1, 2000; 91(4): 798 - 803. [Abstract] [Full Text] [PDF]

				P. A. Grayburn, J. L. Weiss, T. C. Hack, E. Klodas, J. S. Raichlen, M. A. Vannan, A. L. Klein, D. W. Kitzman, S. G. Chrysant, J. L. Cohen, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms J. Am. Coll. Cardiol., July 1, 1998; 32(1): 230 - 236. [Abstract] [Full Text] [PDF]

				S. Ismail, A. R. Jayaweera, G. Camarano, L. W. Gimple, E. R. Powers, and S. Kaul Relation Between Air-Filled Albumin Microbubble and Red Blood Cell Rheology in the Human Myocardium: Influence of Echocardiographic Systems and Chest Wall Attenuation Circulation, August 1, 1996; 94(3): 445 - 451. [Abstract] [Full Text]

				R Gref, Y Minamitake, M. Peracchia, V Trubetskoy, V Torchilin, and R Langer Biodegradable long-circulating polymeric nanospheres Science, March 18, 1994; 263(5153): 1600 - 1603. [Abstract] [PDF]